anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
Community Health Workers (CHWs) play a crucial role in the prevention and management of noncommunicable diseases (NCDs). The COVID-19 pandemic triggered the implementation of crisis-driven responses that involved shifts in the roles of CHWs in terms of delivering services for people with NCDs. Strategically aligning these shifts with health systems is crucial to improve NCD service delivery. The aim of this review was to identify and describe COVID-19-triggered shifting roles of CHWs that are promising in terms of NCD service delivery. We searched Ovid Medline, Embase, CINAHL, Web of Science and CABI for Global Health for relevant articles published between 1 January 2020 and 22 February 2022. Studies that were conducted within a COVID-19 context and focused on the shifted roles of CHWs in NCD service delivery were included. We used Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines to report the findings. A total of 25 articles from 14 countries were included in this review. We identified 12 shifted roles of CHWs in NCD service delivery during COVID-19, which can be categorized in three dimensions: 'enhanced' role of CHWs that includes additional tasks such as medication delivery; 'extended' roles such as the delivery of NCD services at household level and in remote communities; and 'enabled' roles through the use of digital health technologies. Health and digital literacy of people with NCDs, access to internet connectivity for people with NCDs, and the social and organizational context where CHWs work influenced the implementation of the shifted roles of CHWs. In conclusion, the roles of CHWs have shifted during the COVID-19 pandemic to include the delivery of additional NCD services at home and community levels, often supported by digital technologies. Given the importance of the shifting roles in the prevention and management of NCDs, adaptation and integration of these shifted roles into the routine activities of CHWs in the post-COVID period is recommended.
Africa's dual burden of rising incidence of infectious diseases and increasing prevalence of non-communicable diseases (NCDs), such as cardiovascular diseases and diabetes, demands innovative approaches to disease surveillance, response, and cross-border health management in response to growing economic integration and global connectivity. In this context, we propose a discursive framework for the development and implementation of a multi-disease digital health passport (MDDHP) in Africa. The MDDHP would serve as a secure platform for storing and sharing individual health data, offering a comprehensive solution to track and respond to infectious diseases, facilitate the management of NCDs, and improve healthcare access across borders. Empowering individuals to proactively manage their health and improve overall outcomes is a key aspect of the MDDHP. In the paper, we examine the key elements necessary to effectively implement MDDHP, focusing on minimizing risks, maintaining efficacy, and driving its adoption while also taking into consideration the unique contexts of the continent. The paper is intended to provide an understanding of the key principles involved and contribute to the discussion on the development and successful implementation of MDDHP in Africa.
PROBLEM TO BE SOLVED: To provide a technology for remotely controlling plural medical diagnostic systems 24-38. SOLUTION: This system is connected to an internal network 20 of a medical institution or facility 12. A data communication control system 40 acts for connecting the institution through an external network to a remote service provider. A service request and data are generated by the system or the control system. Next, the request is transmitted through the control system to the remote service provider 14 and a response to the request is received by the control system and distributed to the diagnostic systems. In this technology, the system provided with no individual communication function is remotely controlled through the external network, thus its infrastructure and cost are reduced and the linkage of needs in services of the institution can be facilitated.
Subjects who have received treatment with OTL-300 in and completed study TIGET-BTHAL will be included in this study. Subjects received OTL-300 injection administered intraosseously in TIGET-BTHAL study. No study treatment will be administered in this study (207757).
Behçet's disease (BD) is an autoinflammatory disease with multifactorial and polygenic etiology, potentially involving arteries and veins of any size resulting in variable vessel vasculitis. We report a case of an Iranian male who presented with porto-sinusoidal vascular disorder due to venous vasculitis as initial manifestation of BD. Despite immunosuppression, anticoagulation and venous recanalization, he subsequently developed severe nephrotic-range proteinuria mimicking a primary renal disease which was completely and immediately ameliorated by stenting of the vena cava. This demonstrates that the proteinuria was caused by increased intraglomerular pressure due to venous outflow obstruction as a consequence of venous vasculitis. To our knowledge, this is the first report of massive proteinuria caused by venous obstruction of the caval vein in the context of BD. Altogether, this case demonstrates the extensive spectrum of vascular disease in BD.
This invention is directed to a method for assaying the degree of activation of immune cells by stimulating non-resting immune cells to activity with an intracellular-acting stimulant and then measuring the activity of the stimulated immune cells. The stimulant that can be used in this invention will effectively stimulate non-resting immune cells to activity, but will not effectively stimulate resting immune cells to activity. The stimulants that can be used in the invention of this assay act directly as activation probes. These stimulants can discern evidence of previous immune cell activation and will therefore effectively stimulate to activity primed immune cells. Since the stimulant discerns previous immune cell activation, the stimulants of this invention will not effectively stimulate to activity resting immune cells. The assay measurements can be used for a variety of evaluations, including correlating in vitro activity of ex vivo activated (EVA) with clinical outcome of the therapy with such cells.
PURPOSE: The purpose of this study was to identify sex differences in postoperative outcomes and return-to-sport rates after fasciotomy for treatment of chronic exertional compartment syndrome (CECS) of the lower leg. It was hypothesised that male CECS patients would have a higher rate of return to sport than female CECS patients.
METHODS: A retrospective cohort study was conducted involving patients who underwent primary fasciotomy of one to four leg compartments for treatment of CECS at a single centre from 2010 to 2020. Each affected leg was treated as a separate subject. Postoperative outcomes included CECS pain frequency and severity, return to sport and Tegner activity level. Multivariable regression was used to determine if sex was an independent predictor of outcomes after adjusting for demographic and clinical covariates. p < 0.05 were considered significant.
RESULTS: Eighty-one legs (44 M, 37 F) of 47 unique patients (34 of whom had bilateral symptoms) were included with a mean follow-up time of 51.5 ± 31.4 months. Male subjects were older (p < 0.001) and had higher body mass index (p < 0.001) compared to female subjects. Most subjects (84.0%) underwent two- or four-compartment fasciotomies. Female sex was found to be predictive of lower overall postoperative pain severity (p = 0.007), higher odds of return to sport (p = 0.04) and higher postoperative Tegner score (p = 0.005). However, female sex was not predictive of postoperative pain frequency, odds of reoperation or odds of return to sport to at least the presymptomatic level (all p < 0.05).
CONCLUSION: Female sex is independently predictive of reduced overall pain severity, higher odds of return to sport and higher postoperative improvement in Tegner score following fasciotomy for treatment of lower-limb CECS.
LEVEL OF EVIDENCE: III.
The herbal healing cushion is intended to utilize the healing power of dried herbs on the human body. It comprises two layers of fabric provided with a herbal filling and fastening cords. It can be worn on or applied to the back or the back of the neck. According to the invention, the herbal healing cushion is divided up into small component-cushions by quilting seams extending parallel/diagonally to the edges of the cushion, each of these component-cushions being fillable with medicinal herbs. The function of these component-cushions is to prevent displacement of the contents. In the preferrred rectangular shape of the cushion, cords or hook and loop closures are provided on the periphery, and these make it possible to site the cushion easily on the desired position of the body. As a result the cushion can be worn inconspicuously under the clothing over a lengthy period without being perceived as troublesome.
Self-Management Education Program The culturally tailored Diabetes Self-Management Education Program involves the following: 1) an initial 45-minute face-to-face private consultation collaboratively determining goals; followed by 2) six 2-hour weekly educational interactive sessions in a format TBD by aim 1. We will deliver culturally targeted written materials and presentations in these sessions. Participants will be asked to practice self-management behaviors concurrently and for four additional weeks.
Study design:

The investigators will conduct a prospective clinical study in which patients with mCRPC and bone-only disease according to ceCT and bone scan will receive standard-of-care treatment with Radium-223. In addition to standard-of-care systemic treatment, each patient will undergo an additional 68Ga-PSMA-PET/CT scan at baseline and will be followed throughout the treatment with patient reported outcome measure (PROM) questionnaires (Kaiku application) and blood sampling for circulating tumor DNA (ctDNA) analysis. The treating physicians will be blinded to the result of the baseline 68Ga-PSMA-PET/CT scan. Each patient will receive a maximum number of 6 cycles of Radium-223 therapy according to current clinical guidelines and will undergo response evaluation by ceCT and bone scans upon clinical progression. At clinical progression, each patient will undergo a second 68Ga-PSMA-PET/CT to determine the location of disease progression and assess the value of 68Ga-PSMA-PET/CT imaging as a response measure. The clinical response of Radium-223 therapy in the patients with bone-only disease according to 68Ga-PSMA-PET/CT scanning, will be compared to the treatment outcomes collected in our previously reported ROTOR registry. Secondary aims are to determine the value of ctDNA as predictive biomarker and the value of 68Ga-PSMA-PET/CT imaging in the response assessment.
<P>PROBLEM TO BE SOLVED: To select an anatomical chart suitable for a section photographed in a medical image.  <P>SOLUTION: In an image server, a medical image DB, an anatomical chart DB and attribute information DB are constructed. In the attribute DB, a section drawn in each anatomical chart is associated with the file name of each anatomical chart as the attribute of each anatomical chart and recorded. When receiving a request for transferring the anatomical chart, a CPU for the image server retrieves the medical image DB, and reads a medical image whose file name recorded as meta-data in a tag area coincides with the file name included in the request for transfer from the medical image DB. The CPU having read the medical image inputs the medical image in a section recognition part to make the part recognize the photographed section. The CPU which makes the section recognized selects the anatomical chart where the section recognized by the section recognition part coincides with the section recorded in the attribute information DB as the anatomical chart most suitable for the medical image.  <P>COPYRIGHT: (C)2008,JPO&INPIT
This arm of the clinical trial will involve eight weeks of twice weekly heavy load resistance training. Patients in this arm will complete three sets of ten repetitions of unilateral leg press exercise at 70% of predicted one repetition maximum. Both legs will be trained, with the affected limb trained first and the unaffected limb matched for volume at a relative percentage of one repetition maximum.
Those subjects to receive Treatment B will receive once daily ulimorelin on Days 1 to 5. Midazolam will be administered on Day 5 with the last dose of ulimorelin and subjects will be discharged from the study unit on Day 6, at least 30 hours after midazolam dosing.
Introduction. Overweight adolescents are confronted daily with stereotypes that condition their body image, self-esteem, and mood. Objectives. To describe, in adolescents with overweight, the subjective experiences related to the body in daily life and their perceptions regarding the interventions and empathy of the health team. Population and methods. Descriptive study with qualitative approach. Semi-structured interviews were conducted with adolescents aged 11 to 18 years with selfreported mass index (BMI) ≥ 26 and referring to medical or nutritional follow-up for overweight, attended at the Adolescence Service of a hospital in the Autonomous City of Buenos Aires, between October 1, 2021, and May 31, 2022. Results. Twenty adolescents were evaluated, with a median age of 13.5 years, most of them from female sex (16/20). All reported body dissatisfaction from an early age (median age: 10 years old). They mention difficulty dressing due to the lack of different sizes; they even limit sports practice. They suffered weight- related body humiliation at school, in the family, or public (15/20). They perceived weight control in a dual way: weight loss was the primary stimulus for treatment, but its centrality in the consultations generated discomfort. The leading causes of therapeutic abandonment were the impossibility of temporarily sustaining the recommendations and the lack of weight loss. The treating team was willing to listen to the patients but needed to understand their daily experiences, physical, material, esthetic, social conditioning, beliefs, and perceptions. Conclusion. The adolescents included in this study perceived specific interventions of the healthcare team as beneficial, with empathic deficiencies.
In the interventional arm, we will offer a self-administered supervised COVID-19 testing strategy with an investigational device - Abbott's Panbio COVID-19 Antigen Self-test. The self-test process will be facilitated by the COVIDSmart CARE! digital App and platform. Suspected COVID-19 patients will be triaged into one of three action plans: a) clinical care pathways, b) prevention (home quarantine, isolation) pathways, or c) social distancing.
Mild Traumatic Brain Injury (mTBI) in children is a very frequent reason for presentation at the paediatric emergency department. In most cases, the trauma will not lead to intracranial lesions. The first objective for clinicians is therefore to detect all children in need of neurosurgical intervention after mTBI. Although computerized tomography (CT) is currently the modality of choice for acute intracranial haemorrhage identification, care should be taken to avoid unnecessary exposure to ionizing radiation in the developing brain. Monitoring the occurrence of bleeding usually involves an observation period which generally extends from six to twenty-four hours. This time is stressful for the child and parents as well as time and cost consuming for the hospital. In addition to the acute conditions, it has been described that post-concussion symptoms can occur in the weeks or months following the trauma, and neuropsychological follow-up of these children could help prevent or reduce the symptoms. The aim of our study is to find biomarkers that can identify children with clinically important intracranial injury and/or children that will eventually suffer from a post-concussion syndrome.
A method for constructing protein/phospholipid/cholesterol multi-hybrid microscale vesicles based on hydrophobic interaction. The invention belongs to the technical field of vesicle model preparation, and particularly relates to a method for constructing protein/phospholipid/cholesterol multi-hybrid microscale vesicles based on hydrophobic interaction. The invention aims to solve the problems of poor stability of the conventional single-component vesicles, poor permeability of polymer vesicles, almost no flowability of membranes of the vesicles, high permeability of protein vesicles and poor flowability. The method comprises the following steps: 1. Chol-COOH was first grafted onto BSA-NH 2 A surface; 2. adding BSA-NH 2 Coupling with PNIPAM to obtain BSA-Chol/PNIPAM; 3. constructing protein vesicles; 4. phospholipids and protein vesicles are co-assembled into multi-hybrid vesicles based on hydrophobic interactions. The invention relates to a multi-element hybrid microscale vesicle which is constructed by taking the main components of natural cell membranes as primitives.
Type 2 Diabetes Mellitus (T2DM) has become one of the most important diseases of our time. Recent research shows that diabetes has negative effects on bones and that people with diabetes might more likely to break a bone. The investigators don't know the reasons for this, but the investigators suspect that normal bone replacement is slowed down in diabetes and this could slow down the growth of new bone. It is possible that the normal material becomes weaker because sugar-related components ("Advanced Glycation Endproducts") are making the bone more brittle. The investigators have shown in past research that people who have type 2 diabetes are more likely to have both weaker bone with lower "bone material strength" and also higher level of sugar-related components("Advanced Glycation Endproducts"). This study will focus on attempting to lower the sugar-related components("Advanced Glycation Endproducts") by treating a group of patients with type 2 diabetes with an over- the- counter B vitamin, known as vitamin B6 or pyridoxamine for one year. The investigators will compare post-menopausal women both before and after pyridoxamine use and study them in terms of different bone features based on blood tests, bone imaging, a bone indentation test and a measurement of sugar-related components in the skin. This study will help to clarify if using pyridoxamine helps improve bone strength in women with diabetes.
The proposed protocol aims to continue tumor-directed therapy during the typical "break period" in an effort to improve on both local tumor response as well as distant disease control. First, the duration from completion of chemoradiotherapy would increase from 6-8 weeks to 9-11 weeks. As noted above, this may allow for further cell death with resultant pathologic downstaging. Secondly, the protocol calls for continued systemic therapy during the 9-11 week period, thus allowing continuation of therapies directed towards both the primary as well as distant sites of disease. The primary aim of this pilot study would be to establish the feasibility of this intensified neoadjuvant approach, especially with respect to tolerability of the subsequent pelvic surgery. A subsequent phase II portion will evaluate the efficacy of this treatment approach.
BACKGROUND: Individuals with childhood apraxia of speech (CAS) were reported to have genetic variations related to gluten sensitivity and some neuroanatomic changes, which could be associated with alterations in neurotransmitters levels such as glutamate and gamma-aminobutyric acid (GABA). The aim was to measure the levels of antigliadin immunoglobulin A (IgA) antibody, glutamate, and GABA in the plasma of children with CAS compared with children with delayed language development (DLD) and neurotypical (NT) children.
METHODS: The participants (N = 120) were in three groups: Group I for CAS (N = 30), Group II for DLD (N = 60), and Group III for NT (N = 30). The abilities of children in Groups I and II were evaluated. The plasma levels of antigliadin IgA, glutamate, and GABA were determined by enzyme-linked immunosorbent assay.
RESULTS: The intelligence quotient and expressive language age in Group I were low compared with Group II (P = 0.001; 0.004). The levels of antigliadin IgA and glutamate in Group I were higher compared with the other two groups, whereas the level of GABA was lower (P < 0.0001). An imbalance between glutamate and GABA was found in Group I. In Group II, no measures differed from NTs except lower GABA levels (P = 0.0007).
CONCLUSIONS: The elevated levels of antigliadin IgA antibody and glutamate demonstrated high sensitivity and specificity, differentiating children with CAS from children with DLD and NT children. The low levels of GABA contributed to the imbalance between the excitatory and inhibitory neurotransmitters' levels detected in children with CAS.
The present invention relates to a liquid cosmetic product using an organic pigment, which has a clearer color and excellent tinting power when putting on makeup on a skin such as eyes, lips, a face, etc., and a manufacturing method thereof. Conventionally, a liquid cosmetic composition is manufactured by using an inorganic pigment. To solve an existing problem having the low tinting power, hiding power, volatility, etc. and hard dispersion along with easy corruption, the manufacturing method comprises: a stirring process of stirring and grinding a raw material mixed with an increasing agent, a dispersing agent, a surface active agent, and the organic pigment in refined water, and stirring the raw material mixed with the liquid cosmetic product using the matured, filtered, and manufactured organic pigment and the increasing agent, the dispersing agent, the surface active agent, and the organic pigment in the refined water; first and second grinding processes of finely grinding the sufficiently stirred raw material into a nanoparticle by a crash of particles; a maturing process of stabilizing and maturing the ground raw material; and a filtering process of removing impurities included in the matured raw material. Therefore, the present invention enables to make a makeup color development constant and clear when putting on makeup as applying the organic pigment, and to express different colors as well as having good dispersion. The present invention enables to expand a lifespan and minimize a skin trouble by applying a natural preservative.
The present invention relates to a Chinese herbal medicine active substance @ vesicle complex having hair care and growth effects, and a preparation method therefor and the use thereof. The complex comprises a Chinese herbal medicine active substance and a vesicle. The Chinese herbal medicine active substance is encapsulated in the vesicle, wherein a hydrophilic substance is coated in a hydrophilic micro-region thereof, i.e. in a water core; a hydrophobic substance is solubilized between double-layer membranes of the vesicle. In the Chinese herbal medicine active substance @ vesicle complex of the present invention, the Chinese herbal medicine active substance and the vesicle are combined into one, and the core-shell double-layer membrane structure of the vesicle can solubilize hydrophilic and hydrophobic active ingredients in Chinese herbal medicine extracts, and also form a stable Chinese herbal medicine active substance @ vesicle micro-ecological environment around the scalp and hair follicles by virtue of its own selective permeability and sustained-release performance, thereby obtaining the best utilization of the drug efficacy and achieving the effect of hair care and growth. The present invention has better permeability, dispersibility and sustained-release performance, has a simple process, and has good application in the fields of cosmetics, drug delivery and controlled release.